Equitec Proprietary Markets »

Applied Therapeutics shares owned by Equitec Proprietary Markets

Quarter-by-quarter ownership of Applied Therapeutics shares owned by Equitec Proprietary Markets from 13F filings

Historical chart of Equitec Proprietary Markets investment in Applied Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Applied Therapeutics held by Equitec Proprietary Markets consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Applied Therapeutics by Equitec Proprietary Markets

Quarter filed Position value Share count Share price at filing
2025-12-31 $55k 553k 0.10

More positions owned by Equitec Proprietary Markets

Netflix Call Option (NFLX)
Cidara Therapeutics Com New Call Option (CDTX)
Hologic (HOLX)
Avadel Pharmaceuticals Com Shs Call Option (AVDL)
Paramount Skydance Corp Com Cl B (PSKY)
Warner Bros Discovery Com Ser A (WBD)
Electronic Arts Call Option (EA)
Boeing Company Put Option (BA)
Brighthouse Finl (BHF)
Western Midstream Partners L Com Unit Lp Int (WES)
Kayne Anderson Bdc Com Shs (KBDC)
Siriusxm Holdings Common Stock (SIRI)
Wolfspeed Common Stock Put Option (WOLF)
Dynavax Technologies Corp Com New (DVAX)
Strategy Cl A New Call Option (MSTR)

View all positions for Equitec Proprietary Markets

Top funds holding Applied Therapeutics

T. Rowe Price Investment Management
Vanguard Group
Knoll Capital Management
Deltec Asset Management
BlackRock
Renaissance Technologies
Pathstone Holdings
Adage Capital Partners GP
Jane Street
Millennium Management
Geode Capital Management
UBS Group
Deutsche Bank Aktiengesellschaft
Graham Capital Management
State Street Corporation

View all funds holding Applied Therapeutics